Reuters logo
BRIEF-Ablynx and Sanofi enter into a strategic collaboration
July 20, 2017 / 5:14 AM / 5 months ago

BRIEF-Ablynx and Sanofi enter into a strategic collaboration

July 20 (Reuters) - ABLYNX NV:

* ABLYNX AND SANOFI ENTER INTO A STRATEGIC COLLABORATION TO DEVELOP NANOBODY PRODUCT CANDIDATES FOCUSED ON IMMUNE-MEDIATED INFLAMMATORY DISEASES

* ABLYNX NV - ‍COLLABORATION GIVES SANOFI ACCESS TO CERTAIN NANOBODIES IN ABLYNX‘S EXISTING PORTFOLIO​

* ABLYNX NV - ‍SANOFI GAINS EXCLUSIVE GLOBAL RIGHTS TO CERTAIN MULTI-SPECIFIC NANOBODIES AGAINST SELECTED TARGETS​

* ABLYNX NV - ‍FINANCIAL TERMS INCLUDE AN UPFRONT PAYMENT OF EUR 23 MILLION TO ABLYNX​

* ABLYNX NV - ‍ABLYNX WILL RECEIVE RESEARCH FUNDING, ESTIMATED TO AMOUNT TO EUR 8 MILLION FOR INITIALLY SELECTED TARGETS​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below